Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology

Cancer Research

Volumn 73, Issue 8, 2013, Pages 2412-2417

  Prabhakar, Uma ^a   Maeda, Hiroshi ^b   K Jain, Rakesh ^c   Sevick Muraca, Eva M ^e   Zamboni, William ^f   Farokhzad, Omid C ^d   Barry, Simon T ^g   Gabizon, Alberto ^h   Grodzinski, Piotr ^a   Blakey, David C ^g  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SOJO UNIVERSITY   (Japan)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^f University of North Carolina   (United States)

^g ASTRAZENECA   (United Kingdom)

^h HEBREW UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BERAPROST; BLEOMYCIN; DAUNORUBICIN; DOCETAXEL; DOXORUBICIN; ENALAPRIL; GLYCERYL TRINITRATE; ISOSORBIDE DINITRATE; LIPOSOME; NANOPARTICLE; PACLITAXEL; PROSTATE SPECIFIC MEMBRANE ANTIGEN; RICINOMACROGOL; TOPOTECAN; VINCRISTINE; ZINOSTATIN MALEIC ACID STYRENE COPOLYMER;

BREAST METASTASIS; CONFERENCE PAPER; DRUG EFFICACY; DRUG UPTAKE; FLUORESCENCE; GALLBLADDER CANCER; HIGH THROUGHPUT SCREENING; HUMAN; INTERNALIZATION; KAPOSI SARCOMA; KIDNEY CANCER; LIVER CANCER; MOLECULARLY TARGETED THERAPY; NANOMEDICINE; NEAR INFRARED FLUORESCENCE; NONHUMAN; OVARY CANCER; OVERALL SURVIVAL; PANCREAS CANCER; PATIENT SELECTION; PRIORITY JOURNAL; PROSTATE CANCER; SOLID TUMOR; TISSUE DISTRIBUTION; TUMOR MICROENVIRONMENT; TUMOR MODEL; TUMOR VASCULARIZATION;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG DELIVERY SYSTEMS; HUMANS; NANOMEDICINE; NEOPLASMS; PERMEABILITY;

EID: 84876534007     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-12-4561     Document Type: Conference Paper

References (16)

1. Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy-Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 1986;46:6387-92.
2. Harisinghani MG, Barentsz J, Hahn PF, Deserno WM, Tabatabaei S, van de Kaa CH, et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 2003; 19:2491-9.
3. Gaglia JL, Guimaraes AR, Harisinghani M, Turvey SE, Jackson R, Benoist C, et al. Noninvasive imaging of pancreatic islet inflammation in type 1A diabetes patients. J Clin Invest 2011;121: 442-5.
4. Maeda H,Nakamura H, Fang J. TheEPReffect formacromolecular drug delivery to solid tumors: Improved tumor uptake, less systemic toxicity, and improved tumor imaging DReview of the vascular permeability of tumors and the EPR effect. Adv Drug Deliver Rev 2013;65:71-9.
5. Maeda H. Macromolecular therapeutics in cancer treatment: The EPR effect and beyond. J Control Release 2012;164:138-44.
6. Harrington KJ, Mohammadtaghi S, Uster PS, Glass D, Peters AM, Vile RG, et al. Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes. Clin Cancer Res 2001;7:243-54.
7. Sevick-Muraca EM. "Translation of near-infrared fluorescence imaging technologies: Emerging clinical applications." Annu Rev Med 2012; 63:217-31.
8. Hall MA, Pinkston KL, Wilganowski N, Robinson H, Ghosh P, Azhdarinia A, et al. "Comparison of mAbs targeting EpCAM for detection of prostate cancer lymph node metastases with multimodal contrast: Quantitative uPET/CT and NIRF imaging." J Nucl Med 2012;53: 1497-37.
9. Jain RK. Normalizing tumor microenvironment to treat cancer: Bench to bedside to biomarkers. J Clin Oncol. In press, 2013.
10. Kamaly N, Xiao Z, Valencia PM, Radovic-Moreno AF, Farokhzad OC. Targeted polymeric therapeutic nanoparticles: Design, development and clinical translation. Chem Soc Rev 2012;41:2971-3010.
11. Hrkach J, Von Hoff D, Mukkaram Ali M, Andrianova E, Auer J, Campbell T, et al. Preclinical development and clinical translation of a PSMAtargeted docetaxel nanoparticle with a differentiated pharmacological profile. Sci Transl Med 2012;4:128ra39.
12. Caron WP, Rawal S, Song G, Kumar P, Lay JC, Zamboni WC. Bidirectional interaction between nanoparticles and cells of the mononuclear phagocyte system. In: Dobrovolskaia MA, McNeil SE, editors. Immunological properties of Engineered Nanomaterials. Singapore: World Scientific Publishing Co.; 2012.
13. Caron WP, Song G, Kumar P, Rawal S, Zamboni WC. Pharmacokinetic and pharmacodynamic disposition of carrier-mediated agents. Clin Pharmacol Ther 2012;91:802-12.
14. Petersen AL, Hansen AE, Gabizon A, Andresen TL. Liposome imaging agents in personalized medicine. Adv Drug Deliv Rev 2012;64: 1417-35.
15. Fang J, Qin H, Nakamura H, Tsukigawa K, Maeda H. Carbon monoxide, generated by heme oxygenase-1, mediates the enhanced permeability and retention (EPR) effect of solid tumor. Cancer Sci 2012;102:535-41.
16. Jain RK, Stylianopoulos T. Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol 2010;7:653.